Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Human based bioinks to engineer physiologically relevant tissues

Objective

Bioprinting techniques, which integrate 3D printing with tissue engineering by using living cells encapsulated in natural or synthetic biomaterials as bioinks, are paving the way toward devising many innovating solutions for key biomedical and healthcare challenges and heralds' new frontiers in medicine, pharmaceutical, and food industries.

HumanINK aims to validate human based-bioinks to produce robust humanized 3D environments with unprecedented biofunctionality for cell culture that fully recapitulate the native microenvironment of a variety of human tissues and organs.
Under this project human-protein derivative precursors that can be cured upon light exposure to form soft hydrogels with tunable mechanical properties will be tested and validated as bioinks for 3D bioprinting. Such materials provide functional support for cell growth and interact with cells to control their function, guiding the process of tissue morphogenesis. This platform is the first to offer complete human-based material for bioprinting and an easy-to-use solution to create physiologically relevant 3D in vitro cell cultures, accelerate drug discovery or clinical purposes.
The HumanINK will allow to optimize the printability, robustness, reproducibility and scalability of the human-based bioinks. The biological response of multiple human cell types will be investigated and the bioinks will be benchmarked with the main competitors in the market.

Our proposed technology will increase the probability of successful drug development while simultaneously reducing the cost and time of development and supporting animal welfare, reducing animal experimentation. Based on the unique properties of our products, HumanINK represents a unique opportunity to develop materials for tissue engineering and accurate disease models for bridging the gap between fundamental research and drug validation, with a high and broad market potential in pharma companies, clinical institutions, or research groups.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2022-POC2

See all projects funded under this call

Host institution

UNIVERSIDADE DE AVEIRO
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 150 000,00
Address
CAMPUS UNIVERSITÁRIO DE SANTIAGO
3810-193 Aveiro
Portugal

See on map

Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (1)

My booklet 0 0